| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $990.9M | +13.3% |
| Cost of Revenue | $252.6M | +1.2% |
| Gross Profit | $738.3M | +18.2% |
| R&D Expense | $243.5M | +11.4% |
| SG&A Expense | $126.5M | -6.5% |
| Operating Income | $36.8M | +233.4% |
| Pre-tax Income | $34.4M | +191.8% |
| Income Tax | $7.6M | +90.8% |
| Net Income | $26.8M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $428.5M | +2.9% |
| Short-term Investments | $32.8M | -80.7% |
| Accounts Receivable | $264.5M | +3.2% |
| Current Assets | $806.8M | -12.0% |
| Total Assets | $1.21B | -13.3% |
| Current Liabilities | $715.8M | -0.4% |
| Long-term Debt | $369.4M | +0.5% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $298.0M | +26.9% |
| Investing Cash Flow | $120.6M | +150.4% |
| Financing Cash Flow | -$396.5M | -129.4% |
| +164.6% |
| EPS (Basic) | $0.06 | +117.1% |
| EPS (Diluted) | $0.06 | +117.1% |
| Total Liabilities |
| $1.24B |
| -4.5% |
| Stockholders' Equity | -$523.9M | -32.6% |